Cite
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: The DOLPHIN trial protocol of a multi-centre randomised controlled trial
MLA
Abdulla, A.(Alan), et al. The Effect of Therapeutic Drug Monitoring of Beta-Lactam and Fluoroquinolones on Clinical Outcome in Critically Ill Patients: The DOLPHIN Trial Protocol of a Multi-Centre Randomised Controlled Trial. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1143371296&authtype=sso&custid=ns315887.
APA
Abdulla, A. (Alan), Ewoldt, T. M. J. (T. M. J. ., Hunfeld, N. G. M. (Nicole), Muller, A. E. (Anouk), Rietdijk, W. J. R. (W. J. R. ., Polinder, S. (Suzanne), Van Gelder, T. (T. ., Endeman, H. (Henrik), & Koch, B. C. P. (B. C. P. . (2020). The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: The DOLPHIN trial protocol of a multi-centre randomised controlled trial.
Chicago
Abdulla, A. (Alan), T.M.J. (T. M.J.) Ewoldt, N.G.M. (Nicole) Hunfeld, A.E. (Anouk) Muller, W.J.R. (W. J.R.) Rietdijk, S. (Suzanne) Polinder, T. (T.) Van Gelder, H. (Henrik) Endeman, and B.C.P. (B. C.P.) Koch. 2020. “The Effect of Therapeutic Drug Monitoring of Beta-Lactam and Fluoroquinolones on Clinical Outcome in Critically Ill Patients: The DOLPHIN Trial Protocol of a Multi-Centre Randomised Controlled Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1143371296&authtype=sso&custid=ns315887.